Content about MIT

February 7, 2014

A new and possibly transformative technology for rapidly diagnosing and evaluating patients based on their specific genetic profile may soon begin appearing at retail pharmacies and clinics, giving pharmacists and clinicians another tool for advancing patient health outcomes and their own practice capabilities.

A new and possibly transformative technology for rapidly diagnosing and evaluating patients based on their specific genetic profile may soon begin appearing at retail pharmacies and clinics, giving pharmacists and clinicians another tool for advancing patient health outcomes and their own practice capabilities.

Dr. Anita Goel, M.D., Ph.D.

January 3, 2014

Adults who are covered by Medicaid use emergency rooms 40% more than those in similar circumstances who do not have health insurance, according to a new study, co-authored by an MIT economist, that sheds empirical light on the inner workings of health care in the United States.

CAMBRIDGE, Mass. — Adults who are covered by Medicaid use emergency rooms 40% more than those in similar circumstances who do not have health insurance, according to a new study co-authored by an MIT economist that sheds empirical light on the inner workings of health care in the United States.

The study takes advantage of Oregon's recent use of a lottery to assign access to Medicaid, the government-backed healthcare plan for low-income Americans, to certain uninsured adults. The research examines emergency room records for roughly 25,000 people for a period of 18 months.

July 12, 2013

Whole generations of Americans have no memory of a time when doctors routinely made house calls. But with the rapid acceleration of telehealth and telepharmacy technologies — and their increasing use by physicians and pharmacy providers — the virtual house call is bringing remotely delivered health services to thousands of patients where they live, work and shop.

Whole generations of Americans have no memory of a time when doctors routinely made house calls. But with the rapid acceleration of telehealth and telepharmacy technologies — and their increasing use by physicians and pharmacy providers — the virtual house call is bringing remotely delivered health services to thousands of patients where they live, work and shop.

September 10, 2012

A drug maker and medical research institute will work together to identify new treatments for bacterial and viral infections.

CAMBRIDGE, Mass. — A drug maker and medical research institute will work together to identify new treatments for bacterial and viral infections.

AstraZeneca and the Broad Institute, owned jointly by Harvard University and MIT, announced Monday that they would collaborate for two years to develop medicines to treat severe infections, saying the identification of high-quality chemicals for the development of new drugs was a significant challenge. The two will use the Broad Institute's collection of 100,000 chemicals known as diversity-oriented synthesis, or DOS compounds.